Results for tag: "Neuraminidase Inhibitor"

Neuraminidase Inhibitors (NAIs) are a class of drugs used to treat Central Nervous System (CNS) diseases. They are used to treat a variety of conditions, including influenza, bacterial meningitis, and encephalitis. NAIs work by blocking the activity of neuraminidase, an enzyme that helps viruses spread within the body. This prevents the virus from replicating and spreading, thus reducing the severity of the infection. NAIs are also used to treat some forms of cancer, as they can inhibit the growth of tumor cells. The NAI market is a rapidly growing sector of the CNS drug market. It is driven by the increasing prevalence of infectious diseases, as well as the development of new treatments for cancer. The market is highly competitive, with a number of companies offering different formulations of NAIs. Some of the major players in the NAI market include GlaxoSmithKline, Sanofi, Novartis, and Roche. Other companies, such as Merck, Pfizer, and AstraZeneca, also offer NAI products. Show Less Read more